Why Petco (WOOF) Is an Excellent Option for Value Investors
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 09 2025
0mins
Should l Buy WOOF?
Source: NASDAQ.COM
Momentum Investing Strategy: Momentum investors focus on "buying high and selling higher," avoiding traditional strategies of buying low and waiting for recovery, which can be risky due to potential loss of momentum in trending stocks.
Petco Health & Wellness (WOOF) as a Strong Candidate: WOOF shows significant recent price momentum with an 18.1% increase over four weeks and a 48.2% gain over 12 weeks, earning a Momentum Score of A and a Zacks Rank #1 (Strong Buy), indicating it is attractively priced for potential growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy WOOF?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on WOOF
Wall Street analysts forecast WOOF stock price to rise
7 Analyst Rating
2 Buy
4 Hold
1 Sell
Hold
Current: 2.400
Low
3.00
Averages
3.55
High
4.53
Current: 2.400
Low
3.00
Averages
3.55
High
4.53
About WOOF
Petco Health and Wellness Company, Inc. is a pet health and wellness company focused on improving the lives of pets, pet parents, and its own Petco partners. It offers pet parents a full spectrum of product choices with products to address ongoing humanization and premiumization trends in the market. It integrates its product offering with its services business, building on the foundation of treating the whole pet, including their physical, mental and social well-being. Its service offering includes veterinary care, grooming, and training. It operates a network of full-service, general practice veterinary hospitals complemented by prescription and insurance offerings. It operates more than 1,500 pet care centers across the United States, Mexico and Puerto Rico and a growing network of on-site veterinary hospitals and mobile veterinary clinics. It offers a complete pet health and wellness ecosystem accessible through its pet care centers and digitally at petco.com and on the Petco app.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Petco Health and Wellness Stock Rises 33.3% Following Q4 Results, Jefferies Upgrades to Buy Rating
- Stock Performance: Shares of Petco Health and Wellness have increased by 33.3% following the release of Q4 results.
- Analyst Upgrade: Jeffries has upgraded Petco's stock rating to "Buy" based on the positive performance and outlook.
See More
Petco Reports Q4 2025 Earnings with Strategic Outlook
- Strong Financial Performance: Petco achieved a 21% increase in adjusted EBITDA for Q4 2025, reaching $106 million, reflecting significant profitability improvements, while operating cash flow surged by 77%, providing greater financial flexibility for future investments.
- Strategic Execution Completed: The company has completed its North Star strategy, focusing on the 'passionate explorers' customer segment, with 2026 execution centered on four pillars, including new brand launches and own brand expansion to meet customer demands for innovation and expert support.
- Positive Outlook: CFO Sabrina Simmons indicated that net sales for 2026 are expected to be flat to up 1.5%, with adjusted EBITDA forecasted between $415 million and $430 million, demonstrating confidence in future growth despite anticipated store closures of 15 to 20 locations.
- Optimized Inventory Management: Although Q4 net sales declined by 2.4% to $1.52 billion, inventory decreased by 9.7%, indicating successful inventory management while reducing unprofitable sales, thereby enhancing overall operational efficiency.
See More
Midday Stock Highlights: Notable Movements in Multiple Stocks
- Market Decline: Mercado Libre's shares fell over 6% after JPMorgan downgraded its rating from overweight to neutral, citing increased competition and prolonged margin pressures, with the price target cut from $2,650 to $2,100, indicating concerns about future profitability.
- Cruise Industry Pressure: Shares of Royal Caribbean and Carnival dropped 5% and 6%, respectively, as oil prices surged past $100 per barrel, with fuel being one of the largest operating expenses for cruise operators, potentially impacting their profitability.
- Energy Stocks Rise: Constellation Energy and Vistra saw their shares increase by 2% following the Department of Energy's announcement of a plan to leverage existing nuclear energy infrastructure for increased power generation, highlighting the strategic importance of nuclear energy for future growth.
- Pet Health Surge: Petco Health and Wellness shares surged nearly 30% after the company indicated a potential return to sales growth, guiding for full-year revenue growth between flat and 1.5%, exceeding market expectations and reflecting confidence in its business recovery.
See More
Petco's Q1 EBITDA Guidance Surpasses Expectations, Stock Soars 35%
- EBITDA Guidance Beats Expectations: Petco's projected Q1 adjusted EBITDA of $92M to $94M (midpoint $93M) exceeds the consensus of $90.3M, indicating positive progress in profitability and boosting investor confidence.
- Upgrade and Price Target: Jefferies upgraded Petco to a Buy rating with a price target of $5.00, representing a 50% upside from the current price, reflecting analysts' optimism about the company's growth potential.
- Management Execution Improvement: RBC Capital Markets maintains a bullish stance on Petco, noting that management is building an execution track record, and while the market remains cautious, investor confidence in the company's gradual improvements is warming up.
- Strategic Growth Plans: Petco aims for up to 1.5% sales growth in 2026 while expanding its own brands and fresh food offerings, indicating a long-term strategic focus on enhancing operational efficiency and market competitiveness.
See More
Latest Rating Changes on Wall Street
- Morgan Stanley Bullish on Alibaba: Morgan Stanley upgrades Alibaba to a top pick, emphasizing that owning in-house chips significantly enhances its chances of becoming an AI leader, despite facing near-term earnings pressure, the long-term outlook remains positive.
- Wells Fargo Double Upgrades Occidental: Wells Fargo upgrades Occidental from underweight to overweight with a $69 target price, citing its peer-leading capital efficiency trends in the Permian as a significant opportunity, albeit with associated risks.
- Citi Maintains Buy on Delta Air: Citigroup reaffirms its buy rating on Delta Air and issues a positive 30-day catalyst watch, believing that recent macro shocks and fuel price volatility have been largely priced into airline stocks with minimal fuel exposure.
- UBS Upgrades Aptiv to Buy: UBS raises Aptiv's rating from hold to buy, anticipating that the upcoming Versigent spin-off will unlock substantial value, setting a target price of $97.
See More
Bumble Shares Surge 21% on Strong Q4 Results and Positive Guidance
- Bumble's Strong Earnings: Bumble's fourth-quarter results showed strong adjusted EBITDA and revenue, leading to a 21% surge in shares, indicating robust performance in the competitive dating app market and likely attracting further investor interest.
- Netskope's Weak Guidance: Netskope anticipates an adjusted loss of 6 to 7 cents per share for Q1, worse than the 6 cents expected by analysts, resulting in a 17% drop in shares, reflecting market concerns over its future profitability and potential impact on funding.
- Petco's Positive Outlook: Petco's guidance for Q1 adjusted EBITDA between $92 million and $94 million exceeded analyst expectations, causing shares to rise 12%, highlighting strong demand and growth potential in the pet products and services market.
- Hims & Hers Stock Rise: Hims & Hers shares increased over 5% following Eli Lilly's warning about health risks associated with its weight-loss drug, demonstrating market sensitivity to health product issues and investor confidence in the company's future growth.
See More
Petco Health and Wellness Stock Rises 33.3% Following Q4 Results, Jefferies Upgrades to Buy Rating
- Stock Performance: Shares of Petco Health and Wellness have increased by 33.3% following the release of Q4 results.
- Analyst Upgrade: Jeffries has upgraded Petco's stock rating to "Buy" based on the positive performance and outlook.
See More
Petco Reports Q4 2025 Earnings with Strategic Outlook
- Strong Financial Performance: Petco achieved a 21% increase in adjusted EBITDA for Q4 2025, reaching $106 million, reflecting significant profitability improvements, while operating cash flow surged by 77%, providing greater financial flexibility for future investments.
- Strategic Execution Completed: The company has completed its North Star strategy, focusing on the 'passionate explorers' customer segment, with 2026 execution centered on four pillars, including new brand launches and own brand expansion to meet customer demands for innovation and expert support.
- Positive Outlook: CFO Sabrina Simmons indicated that net sales for 2026 are expected to be flat to up 1.5%, with adjusted EBITDA forecasted between $415 million and $430 million, demonstrating confidence in future growth despite anticipated store closures of 15 to 20 locations.
- Optimized Inventory Management: Although Q4 net sales declined by 2.4% to $1.52 billion, inventory decreased by 9.7%, indicating successful inventory management while reducing unprofitable sales, thereby enhancing overall operational efficiency.
See More
Midday Stock Highlights: Notable Movements in Multiple Stocks
- Market Decline: Mercado Libre's shares fell over 6% after JPMorgan downgraded its rating from overweight to neutral, citing increased competition and prolonged margin pressures, with the price target cut from $2,650 to $2,100, indicating concerns about future profitability.
- Cruise Industry Pressure: Shares of Royal Caribbean and Carnival dropped 5% and 6%, respectively, as oil prices surged past $100 per barrel, with fuel being one of the largest operating expenses for cruise operators, potentially impacting their profitability.
- Energy Stocks Rise: Constellation Energy and Vistra saw their shares increase by 2% following the Department of Energy's announcement of a plan to leverage existing nuclear energy infrastructure for increased power generation, highlighting the strategic importance of nuclear energy for future growth.
- Pet Health Surge: Petco Health and Wellness shares surged nearly 30% after the company indicated a potential return to sales growth, guiding for full-year revenue growth between flat and 1.5%, exceeding market expectations and reflecting confidence in its business recovery.
See More
Petco's Q1 EBITDA Guidance Surpasses Expectations, Stock Soars 35%
- EBITDA Guidance Beats Expectations: Petco's projected Q1 adjusted EBITDA of $92M to $94M (midpoint $93M) exceeds the consensus of $90.3M, indicating positive progress in profitability and boosting investor confidence.
- Upgrade and Price Target: Jefferies upgraded Petco to a Buy rating with a price target of $5.00, representing a 50% upside from the current price, reflecting analysts' optimism about the company's growth potential.
- Management Execution Improvement: RBC Capital Markets maintains a bullish stance on Petco, noting that management is building an execution track record, and while the market remains cautious, investor confidence in the company's gradual improvements is warming up.
- Strategic Growth Plans: Petco aims for up to 1.5% sales growth in 2026 while expanding its own brands and fresh food offerings, indicating a long-term strategic focus on enhancing operational efficiency and market competitiveness.
See More
Latest Rating Changes on Wall Street
- Morgan Stanley Bullish on Alibaba: Morgan Stanley upgrades Alibaba to a top pick, emphasizing that owning in-house chips significantly enhances its chances of becoming an AI leader, despite facing near-term earnings pressure, the long-term outlook remains positive.
- Wells Fargo Double Upgrades Occidental: Wells Fargo upgrades Occidental from underweight to overweight with a $69 target price, citing its peer-leading capital efficiency trends in the Permian as a significant opportunity, albeit with associated risks.
- Citi Maintains Buy on Delta Air: Citigroup reaffirms its buy rating on Delta Air and issues a positive 30-day catalyst watch, believing that recent macro shocks and fuel price volatility have been largely priced into airline stocks with minimal fuel exposure.
- UBS Upgrades Aptiv to Buy: UBS raises Aptiv's rating from hold to buy, anticipating that the upcoming Versigent spin-off will unlock substantial value, setting a target price of $97.
See More
Bumble Shares Surge 21% on Strong Q4 Results and Positive Guidance
- Bumble's Strong Earnings: Bumble's fourth-quarter results showed strong adjusted EBITDA and revenue, leading to a 21% surge in shares, indicating robust performance in the competitive dating app market and likely attracting further investor interest.
- Netskope's Weak Guidance: Netskope anticipates an adjusted loss of 6 to 7 cents per share for Q1, worse than the 6 cents expected by analysts, resulting in a 17% drop in shares, reflecting market concerns over its future profitability and potential impact on funding.
- Petco's Positive Outlook: Petco's guidance for Q1 adjusted EBITDA between $92 million and $94 million exceeded analyst expectations, causing shares to rise 12%, highlighting strong demand and growth potential in the pet products and services market.
- Hims & Hers Stock Rise: Hims & Hers shares increased over 5% following Eli Lilly's warning about health risks associated with its weight-loss drug, demonstrating market sensitivity to health product issues and investor confidence in the company's future growth.
See More
